Long-term risk of cardiovascular disease mortality among classic Hodgkin lymphoma survivors.

Lu, Zhenxing; Teng, Yintong; Ning, Xiaodong; Wang, Hao; Feng, Weijing; Ou, Caiwen

Lu, Zhenxing; Teng, Yintong; Ning, Xiaodong; Wang, Hao; Feng, Weijing; Ou, Caiwen.

Afiliação

Lu Z; Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Teng Y; Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Guangzhou, China.
Ning X; Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Guangzhou, China.
Wang H; Department of Cardiology, Laboratory of Heart Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
Feng W; Guangdong Provincial Biomedical Engineering Technology Research Center for Cardiovascular Disease, Guangzhou, China.
Ou C; Sino-Japanese Cooperation Platform for Translational Research in Heart Failure, Guangzhou, China.

Cancer ; 128(18): 3330-3339, 2022 09 15.

Article em En | MEDLINE | ID: mdl-35872619

Assuntos

Doenças Cardiovasculares; Doença de Hodgkin; Estudos de Coortes; Humanos; Incidência; Fatores de Risco; Sobreviventes

Palavras-chave

SEER; cardiovascular disease; classic Hodgkin lymphoma; mortality; temporal trend

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Doenças Cardiovasculares Tipo de estudo: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google